Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Active surveillance for intermediate-risk prostate cancer.

Prostate cancer and prostatic diseases - 1 Mar 2017

Dall'Era M A, Klotz L

Abstract excerpt

BACKGROUND: Utilization of active surveillance (AS) for prostate cancer is increasing. Optimal selection criteria for this approach are undefined and questions remain on how best to expand inclusion beyond typical men with very low- or low-risk disease. We sought to review the current experience with AS for men with intermediate-risk featuresMethods:PubMed was queried for all relevant original publications...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Germ-Line Mutation
Share to Multimodal Imaging

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Neoplasm Grading

Share to Outcome Assessment, Health Care

Share to Population Surveillance

Share to Prostatic Neoplasms

Share to Risk Assessment

Source

Open in PubMed Open full text

Identifiers

PMID: 27801900
DOI: 10.1038/pcan.2016.51
PMCID: PMC5303136

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Active surveillance for intermediate-risk prostate cancer.PMID 27801900Read ↗

Defining high-risk prostate cancer: current status.Semantic proximity Read ↗

Follow-up Analysis of Intermediate-risk Prostate Cancer Patients Staged With Psma PET/CTSemantic proximity Read ↗

Use and assessment of PSA in prostate cancer.Semantic proximity Read ↗

Beyond blood biomarkers: the role of SelectMDX in clinically significant prostate cancer identificationSemantic proximity Read ↗

Improving risk stratification among veterans diagnosed with prostate cancer: impact of the 17-gene prostate score assay.Semantic proximity Read ↗

Temporal changes in the clinical approach to diagnosing prostate cancer.Semantic proximity Read ↗

Prognosis of low-risk prostate cancer patients is favorable despite the presence of pathological prognostic factors: a retrospective studySemantic proximity Read ↗

Prostate cancer family history and eligibility for active surveillance: a systematic review of the literature.Semantic proximity Read ↗

Current Understanding and Management of Intraductal Carcinoma of the Prostate.Semantic proximity Read ↗

Perceived barriers to the adoption of active surveillance in low-risk prostate cancer: A Qualitative Analysis of Community and Academic UrologistsSemantic proximity Read ↗

MRI phenotype of the prostate: Transition zone radiomics analysis improves explanation of prostate-specific antigen (PSA) serum level compared to volume measurement alone.Semantic proximity Read ↗

Prostate cancer multifocality: impact on cancer biology and treatment recommendations.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.